VanEck Associates
XRAY icon

VanEck Associates’s Dentsply Sirona XRAY Stock Holding History

VanEck Associates’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,446
Closed -$27K – 1412
2024
Q4 		$27K Sell
1,446
-110
-7% -$2.33K ﹤0.01% 1327
2024
Q3 		$37K Buy
+1,556
New +$39.7K ﹤0.01% 1288
2022
Q4 		– Sell
-1,274
Closed -$36K – 1465
2022
Q3 		$36K Buy
1,274
+134
+12% +$4.58K ﹤0.01% 1288
2022
Q2 		$41K Buy
+1,140
New +$46.1K ﹤0.01% 1291
2020
Q2 		– Sell
-1,132
Closed -$44K – 1036
2020
Q1 		$44K Buy
1,132
+175
+18% +$8.92K ﹤0.01% 884
2019
Q4 		$54K Sell
957
-193
-17% -$10.8K ﹤0.01% 875
2019
Q3 		$61K Buy
1,150
+227
+25% +$12.2K ﹤0.01% 787
2019
Q2 		$54K Buy
+923
New +$49.6K ﹤0.01% 779

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VanEck Associates's XRAY Position: Q1 2025 in Review

VanEck Associates sold out of Dentsply Sirona (XRAY) in Q1 2025, closing a stake of 1,446 shares — an estimated $27K sold.

VanEck Associates first reported a position in XRAY in Q2 2019 and held it in 8 quarters. The position peaked at $61K in Q3 2019. 359 funds tracked by Wall St. Rank hold XRAY as of Q1 2025.

  • VanEck Associates reported no remaining Dentsply Sirona position as of Q1 2025 after selling out during the quarter.
  • VanEck Associates sold 1,446 Dentsply Sirona shares in Q1 2025, an estimated $27K.
  • VanEck Associates first reported a position in Dentsply Sirona in Q2 2019 and held it in 8 quarters.
  • VanEck Associates's Dentsply Sirona position peaked at $61K in Q3 2019.
  • 359 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2025.

Based on VanEck Associates's 13F filing for Q1 2025, filed 15 May 2025.